Terminated PHASE3 INTERVENTIONAL 2-arm NCT01570530

Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery (PROFACE)

Sponsor: Fundación General Universidad de Valladolid

Updated 5 times since 2017 Last updated: Sep 15, 2014 Started: Jan 31, 2011 Primary completion: Jun 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

End of finantial support

Other Atrial Fibrillation trials with similar outcome

Browse all Atrial Fibrillation trials

This PHASE3 trial investigates Atrial Fibrillation and is currently terminated or withdrawn. Fundación General Universidad de Valladolid leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación General Universidad de Valladolid

Data source: Fundación General Universidad de Valladolid

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valladolid, Spain